Favipiravir, Viral RNA-dependent RNA polymerase inhibitor, 50mg, CAS# 259793-96-9

Favipiravir is an inhibitor of Influenza viruses A, B, and C (IC50's: A = 0.03-0.20 µg/mL H1N1, 0.01-0.30 H2N2, 0.08-0.48 H3N2, 0.14-0.15 H4N2, 0.24-1.60 H7N2, 0.20-0.82 H5N1, 0.35 H1N2; B = 0.04-0.09 µg/mL; C = 0.03-0.06 µg/mL) as well as strains resistant to adamantane-type antivirals, oseltamivir, and zanamivir.1,2,3 It displayed no cytotoxicity in a variety of cells. Favipiravir selectively inhibits viral RNA-dependent RNA polymerase.4 Favipiravir has also shown activity against other viruses including arena, phlebo, hanta, flavi, entero, alpha, respiratory syncytial, and noroviruses.5 In clinical trials for treatment of SARS-CoV-2.6,7

CAS Number: 259793-96-9

Manufacturer Part Number/SKU: 10-4471-50mg-EA

Tags: Focus Biomolecules